Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often
Drugstores say Medicare's $50 obesity drug program is catching on
Trouble getting weight loss drugs covered by insurance? Here's what to know
Microdosing GLP-1s? Here's what doctors say about the weight loss trend
Ozempic may be reshaping the brain, scientists say
Why GLP-1s aren't lowering employers' costs
A new Medicare option for weight loss drugs is coming: Here's what to know

Restrictions on obesity drug coverage force patients to pivot
Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it
Using GLP-1s to maintain a normal weight? There are benefits and risks
GLP-1 obesity drugs can complicate life for people with disordered eating
GLP-1 drugs don't work for everyone. But personalized obesity care in the future might
Wegovy obesity pill now available at pharmacies
5 things to know about the new obesity pill
U.S. regulators approve Wegovy pill for weight loss
GLP-1s don't always work for weight loss. Researchers are trying to figure out why
5 things to know about the new obesity pill
GLP-1 pills are on the way. Here's what to know
Cash price for popular weight loss drug Wegovy dropping 30%, manufacturer says
White House strikes deals for lower prices on obesity drugs
Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole
Weight loss drugs are bringing down the country's obesity rate, a survey shows
Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding
A new chapter for online sales of obesity drug alternatives tests legal limits
Advice for trying GLP-1 drugs for weight loss from a doctor who's been there
Eli Lilly sues companies selling alternative versions of its weight loss drug
The FDA warns patients about counterfeit Ozempic that may be in circulation
, Patients scramble as cheaper obesity drug alternatives disappear
Compound versions of weight loss drugs will no longer be available, FDA rules
Consumers can buy Zepbound and Wegovy direct from drugmakers if they pay cash

GLP-1s have transformed weight loss and diabetes. Is addiction next?

Social Security benefits face big cuts in 2033, unless Congress acts
Medicare and Social Security go-broke dates pushed up due to rising health care costs, new SSA law
Medicare negotiations underway to lower prices for next batch of drugs

Biden's Medicaid director shares lessons learned and concerns for the program's futurec
Medicare targets 15 more drugs for price negotiations — including Ozempic

Thanksgiving is coming. Do I have to worry about overeating and weight gain during the holidays?
Another Ozempic side effect? Facing the holidays with no appetite
Drugmakers and pharmacists battle over who gets to make obesity drugs
Thinking of buying Wegovy online? Here’s what to know about compounding pharmacies